Clinical Trials Directory

Trials / Conditions / Objective Response Rate

Objective Response Rate

11 registered clinical trials studyying Objective Response Rate — 3 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingNeoadjuvant Immunochemotherapy and Postoperative Adjuvant Immunotherapy for Head and Neck Squamous Cell Carcin
NCT07145931
Sun Yat-sen UniversityPhase 2
RecruitingAdebrelimab Combined With Chemotherapy for the Esophageal Squamous Cell Carcinoma
NCT07430579
The Second Hospital of Shandong UniversityN/A
RecruitingTrastuzumab Emtansine (T-DM1) in HER2-positive Breast Cancer Patients With Progressive Disease After TKIs or H
NCT06125834
The First Affiliated Hospital with Nanjing Medical UniversityPhase 2
SuspendedFasting Mimicking Diet Program to ImpRovE ChemoTherapy in Hormone Receptor Postive (HR+), HER2- Breast Cancer
NCT05503108
Leiden University Medical CenterPhase 3
UnknownRadiotherapy Combined With PD-1 Inhibitor and GM-CSF for Advanced Recurrent Metastatic Head and Neck Tumors
NCT05760196
Xiangpan LiPhase 2
UnknownTislelizumab and Radiotherapy for Recurrent Cervical Cancer
NCT05310383
Lei LiPhase 2
UnknownSequential Low-dose Decitabine With PD-1/CD28 CD19 CAR-T in Relapsed or Refractory B-cell Lymphoma
NCT04850560
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 1
UnknownAbraxane With Bevacizumab Biosimilar in Patients With Recurrent, Platinum-resistant Epithelial Ovarian Cancer
NCT04670978
Shandong UniversityPhase 2
UnknownCombination of Nimotuzumab and Radiotherapy for Recurrent Uterine Cervical Squamous Carcinoma
NCT04664244
Lei LiPhase 2
UnknownCamrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine Carcinomas
NCT04635956
Lei LiPhase 2
UnknownReal-world Study for Patients With Advanced Hepatobiliary Tumors
NCT03892577
Peking Union Medical College Hospital—